Abbott Laboratories 2013 Annual Report Download - page 25

Download and view the complete annual report

Please find page 25 of the 2013 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 76

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76

2013 BUSINESS HIGHLIGHTS
DIABETES CARE
• Focused on meeting the needs of insulin users
• FreeStyle Precision Neo, a consumer blood glucose
meter, approved in Europe
• FreeStyle Precision Pro, a professional blood glucose
system, approved in U.S. and Europe
• Next-generation sensing technology oers significant
advantages for people with diabetes
VISION CARE
• Abbott holds the #2 position in the cataract market,
and is the fastest growing global company in this area
23
ABBOTT 2013 ANNUAL REPORT
23
VASCULAR DEVICES
• Launch of TECNIS OptiBlue Intraocular Lens (IOL) in Japan
and TECNIS Toric IOL in the United States strengthen Abbott’s
position in the market for advanced and premium IOLs
• Acquisition of OptiMedica in August 2013 enhances Abbott’s
position in this important market by adding laser-assisted
surgery technology to our portfolio
VASCULAR
• Absorb bioresorbable vascular scaold and Xience Xpedition
drug-eluting stent are each available in more than 45 countries
• MitraClip, the world’s first transcatheter mitral valve
repair device, approved in the U.S. in 2013
• Acquisition of IDEV technologies expands Abbott’s
portfolio of peripheral technology products
Absorb is currently an investigational device in the United States,
limited by federal law to investigational use.